2-Oxo-2,6,7,8-tetrahydro-acenaphthylene-1-carboxylic acid amide

ID: ALA316508

Cas Number: 4708-92-3

PubChem CID: 247358

Max Phase: Preclinical

Molecular Formula: C13H11NO2

Molecular Weight: 213.24

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)C1=C2CCCc3cccc(c32)C1=O

Standard InChI:  InChI=1S/C13H11NO2/c14-13(16)11-8-5-1-3-7-4-2-6-9(10(7)8)12(11)15/h2,4,6H,1,3,5H2,(H2,14,16)

Standard InChI Key:  SFRLORUXHRMRMQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 18  0  0  0  0  0  0  0  0999 V2000
    0.6042    1.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1167    0.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1167    1.8833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6625    1.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6625    0.7958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4292    1.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3750    2.6625    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3333    0.3583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8417    1.9250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8417    0.4958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.1167   -0.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3833    2.0333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5875   -0.8625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0958    1.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0958    0.7958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3125   -0.4667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  3  1  0
  5  2  1  0
  6  1  1  0
  7  3  2  0
  8  5  2  0
  9  6  2  0
 10  6  1  0
 11  2  1  0
 12  4  2  0
 13 11  1  0
 14 12  1  0
 15  8  1  0
 16 13  1  0
  4  5  1  0
  8 16  1  0
 14 15  2  0
M  END

Alternative Forms

Associated Targets(Human)

FGFR3 Tclin Fibroblast growth factor receptor (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor (507 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTR1 Pteridine reductase 1 (345 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 213.24Molecular Weight (Monoisotopic): 213.0790AlogP: 1.46#Rotatable Bonds: 1
Polar Surface Area: 60.16Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 1.49CX LogD: 1.49
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.72Np Likeness Score: 0.55

References

1. Barvian M, Panek R, Lu G, Kraker A, Amar A, Hartl B, Hamby J, Showalter H.  (1997)  1-Oxo-3-aryl-1H-indene-2-carboxylic acid derivatives as selective inhibitors of fibroblast growth factor receptor-1 tyrosine kinase,  (22): [10.1016/S0960-894X(97)10110-X]
2. Ferrari S, Morandi F, Motiejunas D, Nerini E, Henrich S, Luciani R, Venturelli A, Lazzari S, Calò S, Gupta S, Hannaert V, Michels PA, Wade RC, Costi MP..  (2011)  Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase.,  54  (1): [PMID:21126022] [10.1021/jm1010572]

Source